Search results
Author(s):
Gi-Byoung Nam
,
Min Soo Cho
Added:
1 year ago
ESC Congress 2024 — Edoxaban monotherapy significantly improves outcomes in high-risk patients with CAD and atrial fibrillation.Investigators, Dr Gi-Byoung Nam (Ulsan University Hospital, Ulsan, SK) and Dr Min Soo Cho (Asan Medical Center, Seoul, SK) join us to discuss the key findings from the EPIC-CAD trial (NCT03718559).This Korean multi-centre, open-labelled, randomised controlled study…
View more
Author(s):
Cristina Helguera Amezua
,
Laura Pérez Bacigalupe
,
Diego Manuel de la Eranueva
,
et al
Added:
4 days ago
Author(s):
Tobias Geisler
Added:
1 year ago
Author(s):
Francesco Pelliccia
Added:
11 months ago
SCAI 2025 - Insights from antiplatelet therapy after transcatheter aortic valve replacement (TAVR) show patients who received single antiplatelet treatment had significantly lower rates of overall six-month mortality, CV death and non-CV death compared to those treated with double antiplatelet treatment.Dr Francesco Pelliccia (Sapienza University of Rome, Rome, IT) joins us to discuss insights…
View more
Development of Small-molecule SERCA Stimulators
Author(s):
Antonio Zaza
,
Marcella Rocchetti
Added:
9 months ago
Review Article
Author(s):
Jordi Cahís
,
Pablo Carrión-Montaner
,
Jordi Sans
,
et al
Added:
4 days ago
Author(s):
Jordi Cahís
,
Pablo Carrión-Montaner
,
Jordi Sans
,
et al
Added:
5 days ago
Author(s):
Manav Sohal
Added:
1 year ago
Prof. Johanne Silvain
Research Area(s) / Expertise:
Job title: Prof. Johanne Silvain is professor of medicine at the Pierre and Marie Curie University in Paris, France.
Author
Antithrombotics in stable CAD and AF
Author(s):
Massimo Grimaldi
,
Bianca Rocca
Added:
1 month ago
Editorial